Milnacipran for the long-term treatment of fibromyalgia syndrome

CAFC
  • US 7,994,220 B2
  • Filed: 09/26/2006
  • Issued: 08/09/2011
  • Est. Priority Date: 09/28/2005
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating fibromyalgia in a patient suffering from fibromyalgia comprising administering milnacipran, or a pharmaceutically acceptable salt thereof, to the patient according to the following schedule:

  • a) administering 12.5 mg milnacipran/day to the patient for 1 day;

    thenb) administering 25 mg milnacipran/day to the patient for 2 days;

    thenc) administering 50 mg milnacipran/day to the patient for 4 days;

    thend) administering 100 mg milnacipran/day.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×